NO970511D0 - Nye substituerte oksazolidinoner - Google Patents
Nye substituerte oksazolidinonerInfo
- Publication number
- NO970511D0 NO970511D0 NO970511A NO970511A NO970511D0 NO 970511 D0 NO970511 D0 NO 970511D0 NO 970511 A NO970511 A NO 970511A NO 970511 A NO970511 A NO 970511A NO 970511 D0 NO970511 D0 NO 970511D0
- Authority
- NO
- Norway
- Prior art keywords
- substituted oxazolidinones
- newly substituted
- newly
- oxazolidinones
- substituted
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
- C07F9/65844—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a five-membered ring which may be condensed with another ring system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19604223A DE19604223A1 (de) | 1996-02-06 | 1996-02-06 | Neue substituierte Oxazolidinone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO970511D0 true NO970511D0 (no) | 1997-02-05 |
| NO970511L NO970511L (no) | 1997-08-07 |
Family
ID=7784633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO970511A NO970511L (no) | 1996-02-06 | 1997-02-05 | Nye substituerte oksazolidinoner |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US5792765A (no) |
| EP (1) | EP0789025B1 (no) |
| JP (1) | JPH09316073A (no) |
| KR (1) | KR970061888A (no) |
| CN (1) | CN1160051A (no) |
| AR (1) | AR005703A1 (no) |
| AT (1) | ATE200285T1 (no) |
| AU (1) | AU1251697A (no) |
| BG (1) | BG101193A (no) |
| BR (1) | BR9700885A (no) |
| CA (1) | CA2196862A1 (no) |
| CO (1) | CO4560411A1 (no) |
| CZ (1) | CZ34097A3 (no) |
| DE (2) | DE19604223A1 (no) |
| DK (1) | DK0789025T3 (no) |
| EE (1) | EE9700043A (no) |
| ES (1) | ES2157027T3 (no) |
| GR (1) | GR3036015T3 (no) |
| HR (1) | HRP970048A2 (no) |
| HU (1) | HUP9700358A3 (no) |
| ID (1) | ID15881A (no) |
| IL (1) | IL120125A0 (no) |
| MX (1) | MX9700886A (no) |
| NO (1) | NO970511L (no) |
| NZ (1) | NZ314179A (no) |
| PL (1) | PL318277A1 (no) |
| PT (1) | PT789025E (no) |
| SG (1) | SG50791A1 (no) |
| SI (1) | SI0789025T1 (no) |
| SK (1) | SK15897A3 (no) |
| SV (1) | SV1997000009A (no) |
| TN (1) | TNSN97032A1 (no) |
| TR (1) | TR199700092A2 (no) |
| TW (1) | TW350845B (no) |
| YU (1) | YU4397A (no) |
| ZA (1) | ZA97927B (no) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9601666D0 (en) * | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
| US6255304B1 (en) | 1997-05-30 | 2001-07-03 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| JP2002501530A (ja) | 1997-05-30 | 2002-01-15 | ファルマシア・アンド・アップジョン・カンパニー | チオカルボニル官能基を有するオキサゾリジノン抗菌剤 |
| AU9001598A (en) * | 1997-09-11 | 1999-03-29 | Hokuriku Seiyaku Co. Ltd | Thiourea derivatives |
| KR100619639B1 (ko) * | 1997-11-07 | 2006-09-06 | 파마시아 앤드 업존 캄파니 엘엘씨 | 옥사졸리디논의 제조 방법 |
| DE19802239A1 (de) * | 1998-01-22 | 1999-07-29 | Bayer Ag | Neue mit Bicyclen substituierte Oxazolidinone |
| AU764184B2 (en) * | 1998-01-23 | 2003-08-14 | Pharmacia & Upjohn Company | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| PL345162A1 (en) | 1998-06-05 | 2001-12-03 | Astrazeneca Ab | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| GB9821938D0 (en) * | 1998-10-09 | 1998-12-02 | Zeneca Ltd | Chemical compounds |
| JP2000204084A (ja) * | 1998-11-11 | 2000-07-25 | Hokuriku Seiyaku Co Ltd | チオカルバミド酸誘導体 |
| WO2000029396A1 (de) * | 1998-11-17 | 2000-05-25 | Bayer Aktiengesellschaft | Neue substituierte phenyloxazolidon-derivate |
| AU1045300A (en) * | 1998-11-17 | 2000-06-05 | Bayer Aktiengesellschaft | Novel heterocyclyl-substituted oxazolidone derivatives |
| US6403804B1 (en) | 1998-12-07 | 2002-06-11 | Takasago International Corporation | Process for preparing optically active oxazolidinone derivative |
| CA2372233A1 (en) | 1999-05-27 | 2000-12-07 | Pharmacia & Upjohn Company | Bicyclic oxazolidinones as antibacterial agent |
| CN1367780A (zh) * | 1999-07-28 | 2002-09-04 | 法玛西雅厄普约翰美国公司 | 噁唑烷酮类化合物、其制备方法及其应用 |
| US6413981B1 (en) | 1999-08-12 | 2002-07-02 | Ortho-Mcneil Pharamceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| US6608081B2 (en) | 1999-08-12 | 2003-08-19 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| US6297242B1 (en) | 1999-08-12 | 2001-10-02 | Ortho-Mcneil Pharmaceutical, Inc. | N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof |
| GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
| US6518285B2 (en) | 1999-12-21 | 2003-02-11 | Ortho Mcneil Pharmaceutical, Inc. | Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials |
| DK1111583T3 (da) | 1999-12-23 | 2003-09-22 | Hans-Peter Wilfer | Kasse til musikinstrumenter, især guitarer |
| DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| KR100355345B1 (ko) * | 2000-01-21 | 2002-10-12 | 한국과학기술연구원 | 티오펜환을 함유한 신규한 옥사졸리디논 유도체, 그의 제조방법 및 조성물 |
| MY127336A (en) | 2000-03-22 | 2006-11-30 | Upjohn Co | Container for linezolid iv solution |
| US6514529B2 (en) | 2000-03-22 | 2003-02-04 | Pharmacia & Upjohn Company | Oxazolidinone tablet formulation |
| PE20011124A1 (es) | 2000-03-31 | 2001-10-28 | Upjohn Co | Nuevos agentes antibacterianos de benzosultam oxazolidinona |
| GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| DK1301207T3 (da) | 2000-06-30 | 2005-10-10 | Pharmacia & Upjohn Co Llc | Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin |
| PE20030044A1 (es) * | 2000-11-17 | 2003-02-09 | Upjohn Co | Isoxazolinonas biciclicas de formula i |
| CA2405532A1 (en) * | 2001-02-07 | 2002-08-22 | Ortho-Mcneil Pharmaceutical, Inc. | Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods |
| DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
| TW200302095A (en) * | 2002-01-25 | 2003-08-01 | Upjohn Co | Oxazolidinone cotherapy |
| AR038536A1 (es) * | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
| US7141588B2 (en) * | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| IL164195A0 (en) * | 2002-03-29 | 2005-12-18 | Upjohn Co | Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections |
| US7094900B2 (en) * | 2002-08-12 | 2006-08-22 | Pharmacia & Upjohn Company Llc | N-Aryl-2-oxazolidinones and their derivatives |
| AU2002339721A1 (en) * | 2002-09-20 | 2004-04-08 | Lupin Limited | Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents |
| AR043050A1 (es) * | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| AU2003280143A1 (en) * | 2002-11-21 | 2004-06-15 | Pharmacia & Upjohn Company Llc | N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents |
| DE10300111A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
| MXPA05007724A (es) * | 2003-02-07 | 2005-09-30 | Warner Lambert Co | Agentes antibacterianos. |
| MXPA05007937A (es) * | 2003-02-07 | 2005-09-30 | Warner Lambert Co | Agentes antibacterianos. |
| US7012088B2 (en) * | 2003-02-24 | 2006-03-14 | Pharmacia & Upjohn Company | Indolone oxazolidinones and derivatives thereof |
| US20040204463A1 (en) * | 2003-04-01 | 2004-10-14 | Harris Christina Renee | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| WO2005019214A1 (en) * | 2003-08-25 | 2005-03-03 | Warner-Lambert Company Llc | Novel antimicrobial aryloxazolidinone compounds |
| US7304050B2 (en) * | 2003-09-16 | 2007-12-04 | Pfizer Inc. | Antibacterial agents |
| DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
| WO2005082897A1 (en) * | 2004-01-28 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Oxazolidinone antibacterial agents |
| WO2005082900A2 (en) * | 2004-01-28 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Oxazolidinone amidoximes as antibacterial agents |
| US8202843B2 (en) | 2004-02-27 | 2012-06-19 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
| DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
| EP1685841A1 (en) | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
| AU2006231919A1 (en) | 2005-04-06 | 2006-10-12 | Pharmacia & Upjohn Company Llc | 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
| WO2007025089A2 (en) * | 2005-08-24 | 2007-03-01 | Rib-X Pharmaceutical, Inc. | Triazole compounds and methods of making and using the same |
| ES2638427T3 (es) | 2005-08-24 | 2017-10-20 | Melinta Therapeutics, Inc. | Compuestos de triazol y procedimientos de preparación y uso del mismo |
| DE102005045518A1 (de) | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
| CA2624310C (en) | 2005-10-04 | 2014-01-07 | Bayer Healthcare Ag | Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide |
| DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
| DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
| US7649007B2 (en) * | 2006-08-15 | 2010-01-19 | Wyeth Llc | Oxazolidine derivatives as PR modulators |
| WO2008021337A1 (en) | 2006-08-15 | 2008-02-21 | Wyeth | Oxazinan-2-one derivatives useful as pr modulators |
| US7652018B2 (en) * | 2006-08-15 | 2010-01-26 | Wyeth Llc | Imidazolidin-2-one derivatives useful as PR modulators |
| TW200815428A (en) | 2006-08-15 | 2008-04-01 | Wyeth Corp | Oxazolidone derivatives as PR modulators |
| DE102006051625A1 (de) * | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Kombinationstherapie substituierter Oxazolidinone |
| WO2008143649A2 (en) * | 2006-12-04 | 2008-11-27 | Dr. Reddy's Laboratories Limited | Novel oxazolidinone compounds as antiinfective agents |
| TWI429643B (zh) * | 2008-02-22 | 2014-03-11 | Actelion Pharmaceuticals Ltd | 唑啶酮衍生物 |
| WO2018170664A1 (en) * | 2017-03-20 | 2018-09-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4705799A (en) | 1983-06-07 | 1987-11-10 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents |
| US4965268A (en) * | 1987-10-09 | 1990-10-23 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
| US4801600A (en) * | 1987-10-09 | 1989-01-31 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
| US5032605A (en) * | 1987-10-09 | 1991-07-16 | Du Pont Merck Pharmaceutical Company | Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents |
| US4942183A (en) * | 1987-10-16 | 1990-07-17 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents |
| CA1320730C (en) | 1987-10-16 | 1993-07-27 | The Du Pont Merck Pharmaceutical Company | Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents |
| US4948801A (en) * | 1988-07-29 | 1990-08-14 | E. I. Du Pont De Nemours And Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
| US5254577A (en) | 1988-07-29 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
| US5164510A (en) * | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
| DE68918792T2 (de) | 1988-09-15 | 1995-03-30 | Upjohn Co | 5-Indolinyl-5-beta-amidomethyloxazolidin-2-one, 3-(substituierte kondensierte)phenyl-5-beta amidomethyloxazolidin-2-one und 3-(Nitrogen-substituierte)phenyl-5-beta-amidomethyloxazolidin-2-one. |
| JP2669579B2 (ja) * | 1991-10-23 | 1997-10-29 | エーザイ株式会社 | オキサゾリドン誘導体 |
| DE4303303C1 (de) | 1993-02-05 | 1994-02-17 | Freudenberg Carl Fa | Antriebsstrang eines Kraftfahrzeugs |
| DE4332384A1 (de) * | 1993-09-23 | 1995-03-30 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten III |
| TW286317B (no) * | 1993-12-13 | 1996-09-21 | Hoffmann La Roche | |
| DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
| DE4425609A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | Benzofuranyl- und Benzothienyloxazolidinone |
| DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
| HRP960159A2 (en) | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
-
1996
- 1996-02-06 DE DE19604223A patent/DE19604223A1/de not_active Withdrawn
-
1997
- 1997-01-27 HR HR19604223.2A patent/HRP970048A2/hr not_active Application Discontinuation
- 1997-01-31 DK DK97101509T patent/DK0789025T3/da active
- 1997-01-31 PT PT97101509T patent/PT789025E/pt unknown
- 1997-01-31 EP EP97101509A patent/EP0789025B1/de not_active Expired - Lifetime
- 1997-01-31 AT AT97101509T patent/ATE200285T1/de not_active IP Right Cessation
- 1997-01-31 SI SI9730110T patent/SI0789025T1/xx unknown
- 1997-01-31 ES ES97101509T patent/ES2157027T3/es not_active Expired - Lifetime
- 1997-01-31 DE DE59703261T patent/DE59703261D1/de not_active Expired - Fee Related
- 1997-02-03 US US08/794,034 patent/US5792765A/en not_active Expired - Fee Related
- 1997-02-03 NZ NZ314179A patent/NZ314179A/xx unknown
- 1997-02-03 IL IL12012597A patent/IL120125A0/xx unknown
- 1997-02-04 AR ARP970100439A patent/AR005703A1/es unknown
- 1997-02-04 BG BG101193A patent/BG101193A/xx unknown
- 1997-02-04 ID IDP970341A patent/ID15881A/id unknown
- 1997-02-04 TW TW086101259A patent/TW350845B/zh active
- 1997-02-04 TN TNTNSN97032A patent/TNSN97032A1/fr unknown
- 1997-02-04 MX MX9700886A patent/MX9700886A/es unknown
- 1997-02-04 AU AU12516/97A patent/AU1251697A/en not_active Abandoned
- 1997-02-04 PL PL97318277A patent/PL318277A1/xx unknown
- 1997-02-05 NO NO970511A patent/NO970511L/no unknown
- 1997-02-05 KR KR1019970003610A patent/KR970061888A/ko not_active Application Discontinuation
- 1997-02-05 YU YU4397A patent/YU4397A/sh unknown
- 1997-02-05 SK SK158-97A patent/SK15897A3/sk unknown
- 1997-02-05 ZA ZA9700927A patent/ZA97927B/xx unknown
- 1997-02-05 EE EE9700043A patent/EE9700043A/xx unknown
- 1997-02-05 HU HU9700358A patent/HUP9700358A3/hu unknown
- 1997-02-05 TR TR97/00092A patent/TR199700092A2/xx unknown
- 1997-02-05 CZ CZ97340A patent/CZ34097A3/cs unknown
- 1997-02-05 CA CA002196862A patent/CA2196862A1/en not_active Abandoned
- 1997-02-05 BR BR9700885A patent/BR9700885A/pt not_active Application Discontinuation
- 1997-02-05 SG SG1997000259A patent/SG50791A1/en unknown
- 1997-02-06 JP JP9036908A patent/JPH09316073A/ja active Pending
- 1997-02-06 SV SV1997000009A patent/SV1997000009A/es unknown
- 1997-02-06 CO CO97006151A patent/CO4560411A1/es unknown
- 1997-02-06 CN CN97101879A patent/CN1160051A/zh active Pending
-
2001
- 2001-06-08 GR GR20010400867T patent/GR3036015T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO970511D0 (no) | Nye substituerte oksazolidinoner | |
| NO970512D0 (no) | Nye heteroaryl-oksazolidinoner | |
| NO983356D0 (no) | Nye 19-nor-pregnenderivater | |
| NO970374D0 (no) | Nye forbindelser | |
| ID17053A (id) | Derivat-derivat 2-(2-okso-etiliden)-imidazolidin-4-on | |
| DK0935465T3 (da) | Nye substituerede imidazolforbindelser | |
| NO20001938D0 (no) | Nye aryloksy-alkyl-dialkylaminer | |
| DK0906288T3 (da) | Nye forbindelser | |
| DE69715700D1 (de) | Injektionsvorrichtung | |
| NO960268D0 (no) | Nye dialkoksypyridinylbenzimidazolderivater | |
| DE69715987D1 (de) | Spinnvorrichtung | |
| DE59708449D1 (de) | Substituierte p-trifluormethylphenyluracile | |
| DE59707428D1 (de) | Substituierte 1-methyl-3-benzyluracile | |
| ATA95596A (de) | Leiteinrichtung | |
| DE29716570U1 (de) | Achsen-Vorrichtung | |
| ATE275146T1 (de) | Substituierte pyrazol-3-ylbenzazole | |
| NO991097D0 (no) | Nye fremgangsmÕter | |
| NO990072D0 (no) | Nye forbindelser | |
| DK0835798T3 (da) | Styringskontrolindretning | |
| DE59708674D1 (de) | Substituierte 3-phenylpyrazole | |
| DE59712222D1 (de) | Substituierte phenyluracile | |
| NO983505D0 (no) | Nye fenantrider | |
| ATE225600T1 (de) | Langleinen | |
| DE29601750U1 (de) | Drehvorrichtung | |
| DE29715319U1 (de) | Bewässerungsgerät |